AI Image
Popular blood pressure tablets face class II recall
WSB-TV • • general
Key Points:
- The FDA has announced a recall of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets, a common combination medication for high blood pressure.
- The recall affects two lots with expiration dates of May 31, 2027, distributed nationwide, totaling 3,528 30-count bottles and 216 90-count bottles.
- The tablets failed to meet dissolution specifications, which could impact their effectiveness.
- The recall was initially issued on October 7 and upgraded to a Class II recall on October 26, indicating the risk of temporary or medically reversible health issues.
- Patients taking these medications are advised to check their prescriptions and consult healthcare providers regarding alternatives.
